Northern Trust Corp Annexon, Inc. Transaction History

Northern Trust Corp

$761 Billion
Q3 2025

A detailed history of Northern Trust Corp transactions in Annexon, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 787,708 shares of ANNX stock, worth $2.25 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

787,708

Previous 743,224 5.99%

Holding current value

$2.25 Million

Previous $1.78 Million 31.63%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$2.05 - $3.37 $91,192 - $149,911	44,484 Added 5.99%	787,708 $2.35 Million
Q2 2025 Aug 13, 2025	SELL	$1.38 - $2.73 $390,127 - $771,773	-282,701 Reduced 27.56%	743,224 $1.78 Million
Q1 2025 May 13, 2025	SELL	$1.93 - $5.5 $7,382 - $21,037	-3,825 Reduced 0.37%	1,025,925 $1.98 Million
Q4 2024 Feb 14, 2025	BUY	$4.44 - $7.63 $1.06 Million - $1.83 Million	239,685 Added 30.34%	1,029,750 $5.28 Million
Q3 2024 Nov 13, 2024	BUY	$4.49 - $7.2 $1.05 Million - $1.69 Million	234,770 Added 42.28%	790,065 $4.68 Million

Q2 2024 Aug 14, 2024	SELL	$4.33 - $6.79 $1,173 - $1,840	-271 Reduced 0.05%	555,295 $2.72 Million
Q1 2024 May 14, 2024	BUY	$4.03 - $7.81 $758,812 - $1.47 Million	188,291 Added 51.27%	555,566 $3.98 Million
Q4 2023 Feb 13, 2024	BUY	$1.63 - $4.63 $9,841 - $27,955	6,038 Added 1.67%	367,275 $1.67 Million
Q3 2023 Nov 13, 2023	SELL	$2.13 - $3.84 $38,261 - $68,977	-17,963 Reduced 4.74%	361,237 $852,000
Q2 2023 Aug 11, 2023	BUY	$2.1 - $6.37 $626,831 - $1.9 Million	298,491 Added 369.84%	379,200 $1.33 Million
Q1 2023 May 15, 2023	SELL	$3.74 - $7.46 $471 - $939	-126 Reduced 0.16%	80,709 $310,000
Q4 2022 Feb 13, 2023	SELL	$4.56 - $6.61 $620 - $898	-136 Reduced 0.17%	80,835 $417,000
Q3 2022 Nov 14, 2022	BUY	$3.75 - $6.63 $97,267 - $171,968	25,938 Added 47.13%	80,971 $500,000
Q2 2022 Aug 12, 2022	SELL	$2.11 - $4.06 $459,060 - $883,309	-217,564 Reduced 79.81%	55,033 $207,000
Q1 2022 May 13, 2022	SELL	$2.73 - $11.94 $58,937 - $257,772	-21,589 Reduced 7.34%	272,597 $744,000
Q4 2021 Feb 08, 2022	BUY	$11.49 - $22.0 $83,325 - $159,544	7,252 Added 2.53%	294,186 $3.38 Million
Q3 2021 Nov 15, 2021	SELL	$16.35 - $23.4 $114,024 - $163,191	-6,974 Reduced 2.37%	286,934 $5.34 Million
Q2 2021 Aug 13, 2021	BUY	$17.81 - $27.48 $650,919 - $1 Million	36,548 Added 14.2%	293,908 $6.62 Million
Q1 2021 May 12, 2021	BUY	$22.0 - $35.01 $1.75 Million - $2.78 Million	79,339 Added 44.57%	257,360 $7.17 Million
Q4 2020 Feb 11, 2021	BUY	$20.81 - $30.55 $133,912 - $196,589	6,435 Added 3.75%	178,021 $4.46 Million
Q3 2020 Nov 16, 2020	BUY	$17.5 - $30.23 $3 Million - $5.19 Million	171,586 New	171,586 $5.19 Million

Others Institutions Holding ANNX

# of Institutions

151

Shares Held

101M

Call Options Held

88.6K

Put Options Held

32.5K

View Full List

About Annexon, Inc.

Ticker ANNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,617,700
Market Cap $136M
Description
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...

More about ANNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Annexon, Inc. Transaction History